Navigation Links
Bayer Consumer Care Voluntarily Recalls 56 Lots of BRONKAID Caplets Dual Action Formula due to Product Labeling Error

MORRISTOWN, N.J., Dec. 7, 2012 /PRNewswire/ -- In consultation with the U.S. Food and Drug Administration (FDA), Bayer HealthCare's Consumer Care division has begun a voluntary recall of BRONKAID Caplets Dual Action Formula.  Bayer initiated the recall after identifying that certain information was inadvertently excluded from the product carton label.  It is important to note that this represents a labeling omission only.  The quality of the product itself is not affected.

The affected BRONKAID product lot number can be found on both the interior blister package (in black text adjacent to the expiration date) as well as on the exterior carton containing the blister packaging (embossed on the side panel next to the expiration date)

  • Product Name:  BRONKAID Caplets Dual Action Formula
  • Package size/UPC:  24  caplets ( UPC 300240537879)  and 60 caplets ( UPC 300240537855)
  • Lot #s: see below list
  • This product was sold only in the U.S. at retail outlets nationwide.

    As part of a routine internal review, the company found that certain information was not included in the BRONKAID Drug Facts labeling beginning in January 2012.  This information, which is available on the product website, advises to:

    Stop use and ask a doctor if

  • your asthma is getting worse (see Asthma Alert)
  • you have difficulty sleeping
  • you have a rapid heart beat
  • you have tremors, nervousness, or seizure
  • Consumers who purchased packages of BRONKAID Caplets Dual Action Formula from a lot included in this recall (details below) should be mindful of the above warning as well as the full Drug Fact labeling, but may continue to use the product.  Consumers with questions or an interest in a refund should contact Bayer.  Consumers should contact our Consumer Relations Call Center at 1(800) 986-3307 (available Monday - Friday 8:30AM - 5:30PM eastern standard time.) Any consumer with a medical concern or questions should contact their healthcare provider.

    BRONKAID is indicated for relief of bronchial congestion and mild intermittent asthma symptoms, the latter of which should be first diagnosed by a physician.  For full product information and directions for use, see

    About Bayer HealthCare
    Bayer HealthCare, a subgroup of Bayer AG with annual sales of €17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.

    Bayer HealthCare's Consumer Care Division is headquartered in Morristown, New Jersey, USA. It is among the largest marketers of over-the-counter medications and nutritional supplements in the world. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Bayer® Aspirin, ALEVE®, Flanax®/Apronax®, Alka-Seltzer Plus®, Bactine®, RID®, Phillips'® Milk of Magnesia, Midol®, Alka-Seltzer®, Talcid®, Rennie®, Canesten®, Bepanthen®, Bepanthol®, One-A-Day® vitamins, FlintstonesTM vitamins, Supradyn®, Redoxon®, Berocca®, Cal-D-Vita/Elevit®, Vital 50 Plus®, CardioAspirin®.

    BRONKAID Lot Numbers Affected by Voluntary RecallProduct NameLot NumberUPC CodeBRONKAID Dual Action Formula

    24 Coated Caplets


    300240537879BRONKAID Dual Action Formula

    60 Coated Caplets

    NAA0TF3, NAA0TF2, NAA0TF0, NAA0TF1, NAA0TET, NAA0TEW, NAA0TEX, NAA0HHL, NAA0HHK, NAA0HHN, NAA0HHH, NAA0DK5, NAA0DK4, NAA0DK3, NAA0CHE, NAA0CHD, NAA0B3L, NAA0B3K, NAA09XE, NAA09XB, NAA07H2, NAA09XD, NAA07H1, NAA09XA, NAA09XC, NAA07H3, NAA07H4, NAA05BB, NAA05BA, NAA07H0, NAA070D, NAA070C, NAA03PW, NAA05B9, NAA070B, NAA03B8, NAA03B7, NAA02N1, NAA02LW, 244511P, 244501P, 244481P, 244471P, 244491P, 244451P


    SOURCE Bayer HealthCare
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
    2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    3. Bayer Partnership Delivers Industry-First Dose Management Offering
    4. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
    5. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
    6. Bayer Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST)
    7. Hagens Berman Sobol Shapiro LLP and Douglas & London P.C. Announce Proposed Class Action Settlement in Bayer Combination Aspirin Products Litigation
    8. MediSapiens sapprête à fournir à Bayer HealthCare Pharmaceuticals une nouvelle application informatique en nuage pour analyser et visualiser les données génomiques multidimensionnelles
    9. MediSapiens liefert neue Cloud-Computing-App zur Analyse und Visualisierung multidimensionaler Genomdaten an Bayer HealthCare Pharmaceuticals
    10. MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
    11. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
    Post Your Comments:
    (Date:10/8/2015)... Oct. 8, 2015  Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that clinical ... will be presented at the 2015 American College ... include measures of sustained response in IBS-C patients ... randomized Phase 2 trial. The meeting will be ...
    (Date:10/8/2015)... DIEGO , Oct. 8, 2015  Trovagene, ... molecular diagnostics, today announced the presentation of results ... of its Precision Cancer Monitoring SM (PCM) ... be critical for physicians to determine appropriate therapy ... scientific officer of Trovagene is delivering the results ...
    (Date:10/8/2015)... , Oct. 8, 2015  Following months of investigation, ... in the nation alleging that the anticoagulant Xarelto,s recommended dosage ... results. Philadelphia on behalf of ... ischemic stroke because the drug didn,t work as the manufacturer ... numerous other suits shortly on behalf of clients from across ...
    Breaking Medicine Technology:
    ... Md., April 18, 2011 Sigma-Tau Pharmaceuticals, Inc. ... approval from the U.S. Food and Drug Administration ... the oncology medicine ONCASPAR® (pegaspargase).  ONCASPAR is the ... a key component in the treatment of acute ...
    ... April 18, 2011 Quest Diagnostics Incorporated (NYSE: ... testing, information and services, today announced the availability of ... of patient response to peginterferon alpha-based therapy for hepatitis ... the test to physicians and other healthcare providers in ...
    Cached Medicine Technology:
    (Date:10/9/2015)... ... ... A new health tool that helps identify if a sore throat is serious, ... just in time for the cold and flu season, which the Center for Disease ... U.S., the real start of cold/flu season is the start of the school year, ...
    (Date:10/9/2015)... ... October 09, 2015 , ... Smoke alarms can save lives. In fact, ... risk of dying in reported home fires in half. As part of Fire Prevention ... are property installed and maintained. , Half of home fire deaths result from fires ...
    (Date:10/9/2015)... Huntington Beach, CA (PRWEB) , ... October 09, ... ... Rassouli, is now offering a special promotion on Invisalign, the orthodontic system that ... many reasons. The aligners are almost invisible against the teeth, which allow patients ...
    (Date:10/9/2015)... ... October 09, 2015 , ... Matrix IT ... product specifications for TRACTUS, the world’s first sterile field scanner. , ... response to the FDA’s recent Unique Device Identifier (UDI) Final Rule, which will ...
    (Date:10/9/2015)... Washington, DC (PRWEB) , ... October 09, 2015 , ... ... agreement from the US Centers for Disease Control and Prevention (CDC) to improve the ... 14 years that AAFA has been awarded a project by the CDC and allows ...
    Breaking Medicine News(10 mins):
    ... Network of America, LLC (DNoA) announced today the completion ... Blue Cross Blue Shield of Michigan (BCBSM), a nonprofit ... in Michigan, in addition to members of Michigan-headquartered groups ... , The acquisition brings two strategically focused companies -- ...
    ... BCBSM Customers Expanded National Dental Network; Solidify BCBSM Position as ... July 1 Blue Cross Blue Shield of Michigan announced ... acquired by Dental Network of America, LLC (DNoA), a strategic ... and DNoA -- will provide BCBSM with a more competitive ...
    ... , WASHINGTON, July 1 Today,s 65 year old Medicare ... or ,donut hole, is eliminated, says a new analysis of ... Avalere Health. The firm also concludes that although fewer ... by 2020 some of the sickest Medicare beneficiaries will spend ...
    ... 1 At a bargaining session yesterday with SEIU ... at Kaiser Permanente facilities in California and the rest ... ended when the contractor refused to restore the affordable ... the year. Bargaining broke down Tuesday evening as ...
    ... the 2009 pistachio harvest little more than two months away, ... with production expected to exceed 2008 levels. Growing conditions have ... of nutrient-rich pistachios to meet increasing demand. , ... September and is estimated at more than 425 million pounds ...
    ... , WESTCHESTER, Ill., July 1 The Pediatric Brain Tumor ... Fund) and BrainLAB teamed up again this year for the ... in New York City. The June 6 event raised funds ... childhood brain tumors. , , (Photo: ...
    Cached Medicine News:
    ... Tri-Flo® suction catheter design was created ... patients while still providing high suctioning ... (5/6, 8 or 10 Fr) feature ... catheter placement. Our complete catheter line ...
    Tracheal Suction Latex Rubber Catheters - Funnel End...
    Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
    KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning....
    Medicine Products: